PDCD1 and neoplasm: Following this protocol, co-treatment with S-adenosylmethionine and an anti-PD-1 significantly reduced tumor volume and tumor weight, 315 mm3 and 0.2 g, respectively, in comparison with control, 1020 mm3 and 0.68 g, respectively [190].